☆ 4.5 Article

Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis?

PATHOGENS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis

Matthew L. L. Romo et al.

Summary: The study examined the relationship between host immune and endocrine systems and treatment response in patients with extraparenchymal neurocysticercosis (EP-NC). The findings showed that prior to treatment, EP-NC patients had a weak specific immune response and a regulatory response, which may explain the lack of peripheral immunological changes during and after treatment. This weak specific peripheral response may contribute to the chronicity of the infection and the poor treatment response.

PLOS NEGLECTED TROPICAL DISEASES (2023)

添加到收藏夹

Review Immunology

The role of PD-1 signaling in health and immune-related diseases

Ru-Yue Chen et al.

Summary: Programmed cell death 1 receptor (PD-1) and its ligands play a crucial role in immune tolerance, immune homeostasis, and immunosuppression. The PD-1 pathway has been implicated in various diseases, including cancer and autoimmune diseases, and PD-1 blockades have been approved for cancer treatment. This comprehensive review focuses on the structure and expression of PD-1, PD-L1, and PD-L2, the diverse biological functions of PD-1 signaling in health and immune-related diseases, and the immune-related adverse events associated with PD-1 and PD-L1 inhibitors.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Review Oncology

Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis

Adam Szeles et al.

Summary: Elevated levels of soluble PD-L1 (sPD-L1) are associated with poorer prognosis in cancer patients receiving immune checkpoint inhibitor (ICI) therapy, although this association appears to be tumor type dependent. Additionally, sPD-L1 levels may increase during anti-PD-L1 therapy, but this is therapy specific.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

添加到收藏夹

Article Oncology

Soluble PD-L1 reflects cachexia status in patients with gastric cancer and is an independent prognostic marker for relapse-free survival after radical surgery

Yasunori Matsumoto et al.

Summary: Soluble programmed death-ligand 1 (sPD-L1) levels can reflect cachexia status and serve as a prognostic marker for relapse-free survival after radical gastric cancer (GC) surgery. The study found that sPD-L1 levels were associated with factors related to inflammation and nutrition in patients with GC, and patients with the intestinal type had higher sPD-L1 levels than those with the diffuse type. Among patients who received radical treatment, those with high sPD-L1 levels had significantly worse relapse-free survival.

MOLECULAR AND CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden

Abdollah Jafarzadeh et al.

Summary: The expression of PD-1 and its ligands increase in Leishmania infection and lead to immune suppression. Blocking PD-1/PD-L1 interaction can enhance immune response and reduce parasite burden, making it a potential therapeutic strategy.

CYTOKINE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis

Fabio Scirocchi et al.

Summary: This study investigates the correlation between soluble programmed death ligand-1 (sPD-L1) and survival in cancer patients undergoing immunotherapy. The results show that high levels of sPD-L1 are associated with worse overall survival and progression-free survival in cancer patients treated with immunotherapy. Specifically, in non-small cell lung cancer patients, higher levels of sPD-L1 are correlated with poorer survival. sPD-L1 could serve as a non-invasive biomarker that is easily measurable in the blood, helping to select cancer patients before immunotherapy and improve treatment efficacy while avoiding unnecessary treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Immunology

Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options

Yanina Arana et al.

Summary: The study found that interrupting the PD-1/PD-L1 axis during acute T. cruzi infection may not necessarily enhance the immune response, but could lead to increased parasitemia and sustained upregulation of other co-inhibitory receptors. Therefore, using immune therapeutic approaches targeting the PD-1/PD-L1 axis in CD may be risky and more research is needed to better understand T cell immune regulation.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

The Expression Levels and Concentrations of PD-1 and PD-L1 Proteins in Septic Patients: A Systematic Review

Mutiara Indah Sari et al.

Summary: This systematic review evaluates the expression levels and concentrations of PD-1 and PD-L1 proteins in septic and other infectious patients.

DIAGNOSTICS (2022)

添加到收藏夹

Article Immunology

Soluble programmed death-1 (sPD-1) as predictor of early surgical outcomes of paediatric cystic echinococcosis

Eya Ben Salah et al.

Summary: The study found that soluble programmed death-1 (sPD-1), sPD-1 ligand (sPD-L1), and anti-recP29 antibody concentrations can be valuable predictors of early surgical treatment outcomes in young cystic echinococcosis (CE) patients. This suggests that these biomarkers could be useful for evaluating surgical efficacy and prognosis in pediatric CE cases.

PARASITE IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis

Fadi Jebbawi et al.

Summary: The study demonstrated that PD-L1 blockade significantly reduced parasite load, promoted T-cell activity, restored antigen presenting cells, suppressed NK and NKT cells, and improved control of E. multilocularis infection.

PARASITE IMMUNOLOGY (2021)

添加到收藏夹

Article Parasitology

Immunological exhaustion and functional profile of CD8+ T lymphocytes as cellular biomarkers of therapeutic efficacy in chronic Chagas disease patients

Elena Perez-Anton et al.

ACTA TROPICA (2020)

添加到收藏夹

Review Infectious Diseases

Subarachnoid neurocysticercosis: emerging concepts and treatment

Theodore E. Nash et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Oncology

Soluble PD-L1 and Circulating CD8+PD-1+and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients

G. Mazzaschi et al.

LUNG CANCER (2020)

添加到收藏夹

Review Parasitology

Could Differences in Infection Pressure Be Involved in Cysticercosis Heterogeneity?

Pedro T. Hamamoto Filho et al.

TRENDS IN PARASITOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Endoscopic intervention for intraventricular neurocysticercal cyst: Challenges and outcome analysis from a single institute experience

Subhas Konar et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2020)

添加到收藏夹

Article Oncology

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma

Boyang Chang et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis

Rocio Osorio et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load

Alessandra M. da Fonseca-Martins et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Immunology

Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction

Mai Okuyama et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Oncology

Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer

Yusuke Okuma et al.

CLINICAL LUNG CANCER (2018)

添加到收藏夹

Review Immunology

The diverse functions of the PD1 inhibitory pathway

Arlene H. Sharpe et al.

NATURE REVIEWS IMMUNOLOGY (2018)

添加到收藏夹

Article Infectious Diseases

Extraparenchymal neurocysticercosis: Demographic, clinicoradiological, and inflammatory features

Mariana Marcin Sierra et al.

PLOS NEGLECTED TROPICAL DISEASES (2017)

添加到收藏夹

Article Immunology

Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis

A. Arce-Sillas et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Role of soluble programmed death-1 (sPD-1) and sPD- ligand 1 in patients with cystic echinococcosis

Yanhua Li et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)

添加到收藏夹

Article Clinical Neurology

New diagnostic criteria for neurocysticercosis: Reliability and validity

Arturo Carpio et al.

ANNALS OF NEUROLOGY (2016)

添加到收藏夹

Article Immunology

Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis

Hector H. Garcia et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Immunology

Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients

Paola Lasso et al.

JOURNAL OF IMMUNOLOGY (2015)

添加到收藏夹

Review Cell Biology

The PD-1/PD-Ls pathway and autoimmune diseases

Suya Dai et al.

CELLULAR IMMUNOLOGY (2014)

添加到收藏夹

Article Immunology

Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity

Graciela Cardenas et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2014)

添加到收藏夹

Review Infectious Diseases

Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease

Agnes Fleury et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)

添加到收藏夹

Article Oncology

Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1

Mi-Young Song et al.

JOURNAL OF IMMUNOTHERAPY (2011)

添加到收藏夹

Review Immunology

The PD-1 pathway in tolerance and autoimmunity

Loise M. Francisco et al.

IMMUNOLOGICAL REVIEWS (2010)

添加到收藏夹

Article Parasitology

Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis

LI Terrazas et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.